newsfilter
← Latest News
GlobeNewswire·

Ovid Therapeutics to Participate in Upcoming Investor Conferences

NEW YORK, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ:OVID), a biopharmaceutical company developing small molecule medicines to treat brain disorders and symptoms caused by excess neural